Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics

OBJECTIVE: Second-generation antipsychotics (SGAs) increase the risk of metabolic syndrome (MetS). Despite the risk of MetS, SGAs may have to be continued with change in some patients. The aim of this study was to trace the evolution of MetS in these patients. METHODS: Patients with schizophrenia wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Seong Hoon, Lee, Nam Young, Kim, Se Hyun, Chung, In Won, Youn, Tak, Kang, Ung Gu, Ahn, Yong Min, You, Han Young, Kim, Yong Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018140/
https://www.ncbi.nlm.nih.gov/pubmed/29940717
http://dx.doi.org/10.30773/pi.2018.01.18.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018140/
https://www.ncbi.nlm.nih.gov/pubmed/29940717
http://dx.doi.org/10.30773/pi.2018.01.18.1

Ejemplares similares